Genetic etiologies associated with severe epilepsies in infancy;Etiologías genéticas asociadas con epilepsias graves del lactante

Archivos Argentinos de Pediatria

Volumn 110, Issue 5, 2012, Pages 421-429

  Fejerman, Natalio ^a  

^a NONE

Author keywords

Chromosomic abnormalities; Epileptic encephalopathies; Genetic diseases; Infancy; Severe epilepsies

Indexed keywords

BRAIN DISEASE; BRAIN MALFORMATION; CHROMOSOME ABERRATION; COMPARATIVE GENOMIC HYBRIDIZATION; COPY NUMBER VARIATION; CORTICAL DYSPLASIA; DISEASE SEVERITY; ELECTROENCEPHALOGRAPHY; EPILEPSY; GENE MUTATION; HUMAN; INBORN ERROR OF METABOLISM; INFANCY; INFANT; INFANTILE SPASM; LENNOX GASTAUT SYNDROME; MITOCHONDRIAL ENCEPHALOPATHY; NEUROECTODERMOSIS; PHENOTYPE; REVIEW;

ALGORITHMS; CHROMOSOME ABERRATIONS; EPILEPSY; HUMANS; INFANT; MUTATION; SEVERITY OF ILLNESS INDEX; SYNDROME;

EID: 84868139594     PISSN: 03250075     EISSN: 16683501     Source Type: Journal    
DOI: 10.5546/aap.2012.421     Document Type: Review

References (64)

1. Engel J Jr. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia 2001;42(6):796-803.
2. Engel J Jr. Report of the ILAE classification core group. Epilepsia 2006;47(9):1558-68.
3. Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 2010;51(4):676-85.
4. De Coriat LF, Fejerman N. Epilepsia en flexión generalizada en niños con trisomía 21 (mongolismo). Premio "Bernardo E. Sas" otorgado por la Sociedad Argentina de Pediatría. La Semana Médica 1969. Págs.493-500.
5. Bahi-Buisson N, Eisermann M, Dulac O. Down Syndrome. En: Shorvon SD, Andermann F, Guerrini R (eds.) The causes of Epilepsy. Cambridge: Cambridge Medicine; 2011. Págs.265-71.
6. Caraballo R, Cersósimo R, Garro F, Kessler K, et al. Infantile spasms in Down syndrome: A good response to vitamin B6. J Pediatr Neurol 2004;2(1):15-9.
7. Caraballo R, Fejerman N. Pyridoxine-dependent epilepsy, S. Gilman, Editor MedLink Neurology. San Diego: Medlink Corporation; 2009.
8. Bahi-Buisson N, Guttierrez-Delicado E, Soufflet C, Río M, et al. Spectrum of epilepsy in terminal 1p36 deletion syndrome. Epilepsia 2008;49(3):509-15. (Pubitemid 351294538)
9. Fejerman N. Fenotipos conductuales. En: Fejerman N (ed.). Trastornos del desarrollo en niños y adolescentes. Buenos Aires: Editorial Paidós; 2010.Págs.269-80.
10. Cersosimo R, Caraballo R, Espeche A, Cassar L, et al. Angelman syndrome: the electroclinical characteristics in 35 patients. Rev Neurol 2003;37(1):14-8. (Pubitemid 37028613)
11. Battaglia A, Gurrieri F, Bertini E, Bellacosa A, et al. The inv dup(15) syndrome: a clinically recognizable syndrome with altered behavior, mental retardation, and epilepsy. Neurology 1997;48(4):1081-6.
12. Deprez L, Jansen A, De Jonghe P. Genetics of epilepsy syndromes starting in the first year of life. Neurology 2009;72(3):273-81.
13. Pong W, Pal DK, Chung WK. Developments in molecular genetic diagnostics: an update for the pediatric epilepsy specialist. Pediatr Neurol 2011;44(5):317-27.
14. Paciorkowski AR, Thio LL, Dobyns WB. Genetic and biologic classification of infantile spasms. Pediatr Neurol 2011;45(6):355-67.
15. Mastrangelo M, Leuzzi V. Genes of early-onset epileptic encephalopathies: from genotype to phenotype. Pediatr Neurol 2012;46(1):24-31.
16. Dravet C. The core Dravet syndrome phenotype. Epilepsia 2011;52(Suppl 2):3-9.
17. Chiron C, Dulac O. The pharmacologic treatment of Dravet syndrome. Epilepsia 2011;52(Suppl 2):72-5.
18. Caraballo RH, Cersosimo RO, Sakr D, Cresta A, et al. Ketogenic diet in patients with Dravet syndrome. Epilepsia 2005;46(9):1539-44.
19. Caraballo RH, Fejerman N. Dravet syndrome: a study of 53 patients. Epilepsy Res 2006;70(Suppl 1):S231-8.
20. Caraballo RH, Nonpharmacologic treatments of Dravet syndrome: focus on the ketogenic diet. Epilepsia 2011;52 (Suppl 2):79-82.
21. Claes L, Ceulemans B, Audenaert D, Smets K, et al. De novo SCN1A mutations are a major cause of severe myoclonic epilepsy of infancy. Hum Mutat 2003;21(6):615-21. (Pubitemid 36667351)
22. Claes L, Del-Favero J, Ceulemans B, Lagae L, et al. De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet 2001;68(6):1327-32. (Pubitemid 32510608)
23. Marini C, Scheffer IE, Nabbout R, Suls A, et al. The genetics of Dravet syndrome. Epilepsia 2011; 52(Suppl 2):24-9.
24. Dravet C, Guerrini R. Topics in Epilepsy: Dravet syndrome. John Libbey Eurotext: Montrouge; 2011.
25. Scheffer IE, Zhang YH, Jansen FE, Dibbens L. Dravet syndrome or genetic (generalized) epilepsy with febrile seizures plus? Brain Dev 2009;31(5):394-400.
26. Ottman R, Hirose S, Jain S, Lerche H, et al. Genetic testing in the epilepsies-report of the ILAE Genetics Commission. Epilepsia 2010;51(4):655-70.
27. Depienne C, Bouteiller D, Keren B, Cheuret E, et al. Sporadic infantile epileptic encephalopathy caused by mutations in PCDH19 resembles Dravet syndrome but mainly affects females. PLoS Genet 2009;5(2):e1000381.
28. Specchio N, Marini C, Terracciano A, Mei D., et al. Spectrum of phenotypes in female patients with epilepsy due to protocadherin 19 mutations. Epilepsia 2011;52(7):1251-7.
29. Amir RE, Van den Veyver IB, Schultz R, Malicki DM, et al. Influence of mutation type and X chromosome inactivation on Rett syndrome phenotypes. Ann Neurol 2000;47(5):670-9. (Pubitemid 30261908)
30. Jacob FD, Ramaswamy V, Andersen J, Bolduc FV. Atypical Rett syndrome with selective FOXG1 deletion detected by comparative genomic hybridization: case report and review of literature. Eur J Hum Genet 2009;17(12):1577-81.
31. Bahi-Buisson N, Kaminska A, Boddaert N, Rio M, et al, The three stages of epilepsy in patients with CDKL5 mutations. Epilepsia 2008;49(6):1027-37. (Pubitemid 351793996)
32. Stromme P, Sundet K, Mork C, Cassiman JJ, et al. X linked mental retardation and infantile spasms in a family: new clinical data and linkage to Xp11.4-Xp22.11. J Med Genet 1999;36(5): 374-8. (Pubitemid 29221872)
33. Guerrini R, Marini C. West syndrome and Lennox-Gastaut syndrome. En: Shorvon SD, Andermann F, Guerrini R (eds.) The causes of Epilepsy. Cambridge: Cambridge Medicine; 2011. Págs.119-34.
34. Sartori S, Polli R, Bettella E, Rossato S, et al. Pathogenic role of the X-linked cyclin-dependent kinase-like 5 and aristaless-related homeobox genes in epileptic encephalopathy of unknown etiology with onset in the first year of life. J Child Neurol 2011; 26(6):683-91.
35. Saitsu H, Kato M, Shimono M, Senju A, et al. Association of genomic deletions in the STXBP1 gene with Ohtahara syndrome. Clin Genet 2012;81(4):399-402.
36. Hamdan FF, Piton A, Gauthier J, Lortie A, et al. De novo STXBP1 mutations in mental retardation and nonsyndromic epilepsy. Ann Neurol 2009;65(6):748-53.
37. Mignot C, Moutard ML, Trouillard O, Gourfinkel-An I, et al. STXBP1-related encephalopathy presenting as infantile spasms and generalized tremor in three patients. Epilepsia 2011;52(10):1820-7.
38. Pavone P, Spalice A, Polizzi A, Parisi P, et al. Ohtahara syndrome with emphasis on recent genetic discovery. Brain Dev 2012;34(6):459-68.
39. Coppola G, Plouin P, Chiron C, Robain O, et al. Migrating partial seizures in infancy: a malignant disorder with developmental arrest. Epilepsia 1995;36(10):1017-24.
40. Caraballo RH, Fontana E, Darra F, Cassar L, et al. Migrating focal seizures in infancy: analysis of the electroclinical patterns in 17 patients. J Child Neurol 2008;23(5):497-506. (Pubitemid 351566861)
41. Coppola G, Veggiotti P, Del Giudice EM, Bellini G, et al. Mutational scanning of potassium, sodium and chloride ion channels in malignant migrating partial seizures in infancy. Brain Dev 2006;28(2):76-9. (Pubitemid 43197586)
42. Carranza Rojo D, Hamiwka L, McMahon JM, Dibbens LM, et al. De novo SCN1A mutations in migrating partial seizures of infancy. Neurology 2011;77(4):380-3.
43. Poduri A, Chopra SS, Neilan EG, Christina Elhosary P, et al. Homozygous PLCB1 deletion associated with malignant migrating partial seizures in infancy. Epilepsia 2012. doi: 10.1111/j.1528-1167.2012.03538.x.
44. Weckhuysen S, Mandelstam S, Suls A, Audenaert D, et al. KCNQ2 encephalopathy: emerging phenotype of a neonatal epileptic encephalopathy. Ann Neurol 2012;71(1):15-25.
45. Lee HY, Huang Y, Bruneau N, Roll P, et al. Mutations in the novel protein PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions. Cell Rep 2012;1(1):2-12.
46. Cloarec R, Bruneau N, Rudolf G, Massacrier A, et al., PRRT2 links infantile convulsions and paroxysmal dyskinesia with migraine. Neurology 2012.
47. Ficicioglu C, Bearden D. Isolated neonatal seizures: when to suspect inborn errors of metabolism. Pediatr Neurol 2011;45(5):283-91.
48. Caraballo R, Garro F, Cersosimo RC, Buompadre C, et al. Pyridoxine dependence: the importance of the clinical diagnosis and early treatment. Rev Neurol 2004;38(1):49-52. (Pubitemid 38252033)
49. Schmitt B, Baumgartner M, Mills PB, Clayton PT, et al. Seizures and paroxysmal events: symptoms pointing to the diagnosis of pyridoxine-dependent epilepsy and pyridoxine phosphate oxidase deficiency. Dev Med Child Neurol 2010;52(7):e133-42.
50. Gallagher RC, Van Hove JL, Scharer G, Hyland K, et al. Folinic acid-responsive seizures are identical to pyridoxine-dependent epilepsy. Ann Neurol 2009;65(5):550-6.
51. Segal B, Grinspan ZM, Mandel AM., Gospe SM Jr. Biomarkers aiding diagnosis of atypical presentation of pyridoxine-dependent epilepsy. Pediatr Neurol 2011;44(4):289-91.
52. Mills PB, Footitt EJ, Mills KA, Tuschl K, et al. Genotypic and phenotypic spectrum of pyridoxine-dependent epilepsy (ALDH7A1 deficiency). Brain 2010; 133(Pt 7):2148-59.
53. Shimomura K. The K(ATP) channel and neonatal diabetes. Endocr J 2009;56(2):165-75.
54. Pong AW, Geary BR, Engelstad KM, Natarajan A, et al. Glucose transporter type I deficiency syndrome: Epilepsy phenotypes and outcomes. Epilepsia 2012; doi: 10.1111/j.1528-1167.2012.03592.xs.
55. Ramaekers VT, Blau N. Cerebral folate deficiency. Dev Med Child Neurol 2004;46(12):843-51. (Pubitemid 39549660)
56. Mangold S, Blau N, Opladen T, Steinfeld R, et al. Cerebral folate deficiency: a neurometabolic syndrome? Mol Genet Metab 2011;104(3):369-72.
57. Gordon N. Cerebral folate deficiency. Dev Med Child Neurol 2009;51(3):180-2.
58. Nguyen KV, Ostergaard E, Ravn SH, Balslev T, et al. POLG mutations in Alpers syndrome. Neurology 2005;65(9):1493-5. (Pubitemid 41552791)
59. Isohanni P, Hakonen AH, Euro L, Paetau I, et al. POLG1 manifestations in childhood. Neurology 2011; 76(9): 811-5.
60. Saneto RP, Lee IC, Koenig MK, Bao X, et al. POLG DNA testing as an emerging standard of care before instituting valproic acid therapy for pediatric seizure disorders. Seizure 2010;19(3):140-6.
61. Lee HF, Chi CS, Tsai CR, Chen CH. Epileptic seizures in infants and children with mitochondrial diseases. Pediatr Neurol 2011;45(3):169-74.
62. Dale RC, Vincent A. Inflammatory and autoimmune disorders of the nervous system in children. Clinics in Developmental Medicine. Londres: Mac Keith Press; 2010.
63. Singh R, Gardner RJ, Crossland KM, Scheffer IE, et al. Chromosomal abnormalities and epilepsy: a review for clinicians and gene hunters. Epilepsia 2002;43(2):127-40. (Pubitemid 34225992)
64. Mulley JC, Mefford HC. Epilepsy and the new cytogenetics. Epilepsia 2011;52(3):423-32.